ClinicalTrials.govpublic full text
CD38 mAb Induction + Azathioprine Maintenance for Chronic Active AMR in Kidney Transplant Recipients
kidney transplantation, antibody-mediated rejection, daratumumab, banff 2022 classification, azathioprine, natural killer cell, donor specific antibody, egfr slope, chronic active amr, cd38 antibody, sequential immunosuppression, interventional
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 894903
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.